WELLS FARGO & COMPANY/MN - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 29 filers reported holding CANCER GENETICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2019$01,0000.0%0.00%
Q2 2019$01,0000.0%0.00%
Q1 2019$01,0000.0%0.00%
Q4 2018$0
-100.0%
1,000
-73.7%
0.00%
Q3 2018$4,000
+100.0%
3,800
+111.1%
0.00%
Q2 2018$2,000
-92.9%
1,800
-89.3%
0.00%
Q1 2018$28,000
+3.7%
16,800
+18.3%
0.00%
Q4 2017$27,000
-37.2%
14,200
-10.3%
0.00%
Q3 2017$43,000
-10.4%
15,823
+31.9%
0.00%
Q2 2017$48,000
+6.7%
11,995
+10.4%
0.00%
Q1 2017$45,000
+542.9%
10,865
+114.1%
0.00%
Q4 2016$7,000
-22.2%
5,0750.0%0.00%
Q3 2016$9,000
-10.0%
5,0750.0%0.00%
Q2 2016$10,000
-28.6%
5,0750.0%0.00%
Q1 2016$14,000
-30.0%
5,075
-18.1%
0.00%
Q4 2015$20,000
-54.5%
6,200
+10.7%
0.00%
Q3 2015$44,000
-46.3%
5,600
-20.0%
0.00%
Q2 2015$82,000
-14.6%
7,000
-42.6%
0.00%
Q1 2015$96,000
+152.6%
12,200
+114.0%
0.00%
Q4 2014$38,000
-53.1%
5,700
-36.9%
0.00%
Q3 2014$81,000
-20.6%
9,0300.0%0.00%
Q2 2014$102,000
-32.5%
9,030
-9.9%
0.00%
Q1 2014$151,000
+287.2%
10,020
+257.9%
0.00%
Q4 2013$39,000
+30.0%
2,800
+86.7%
0.00%
Q3 2013$30,0001,5000.00%
Other shareholders
CANCER GENETICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 23,937$187,0003.26%
Millrace Asset Group, Inc. 166,083$1,297,0001.43%
Sterneck Capital Management, LLC 56,950$445,0000.24%
GRUBER & MCBAINE CAPITAL MANAGEMENT LLC 83,900$655,0000.18%
Quality Growth Management, Inc. 23,500$184,0000.15%
TURNER INVESTMENTS LLC 99,930$781,0000.14%
ARDSLEY ADVISORY PARTNERS LP 70,700$552,0000.08%
Granite Investment Partners, LLC 110,511$863,0000.07%
DIKER MANAGEMENT LLC 23,015$180,0000.03%
Stevens First Principles Investment Advisors 1,000$8,0000.01%
View complete list of CANCER GENETICS INC shareholders